Docoh
Loading...

BFRA Biofrontera

Biofrontera AG operates as a biopharmaceutical company, which engages in the development, sale and distribution of dermatological drugs and medical cosmetics for the care, protection and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria and migraine prophylaxis. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.

Company profile

Ticker
BFRA, BFFTF
Exchange
CEO
Hermann Luebbert
Employees
Incorporated
Location
Fiscal year end
SEC CIK

BFRA stock data

(
)

Calendar

21 Apr 20
12 Apr 21
31 Dec 21

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

97.3% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 2 1 +100.0%
Opened positions 1 1
Closed positions 0 2 EXIT
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 188.42M 102.66M +83.5%
Total shares 27.6M 14.2M +94.4%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Deutsche Balaton Aktiengesellschaft 14.2M $102.66M 0.0%
Maruho 13.4M $85.76M NEW
Largest transactions
Shares Bought/sold Change
Maruho 13.4M +13.4M NEW
Deutsche Balaton Aktiengesellschaft 14.2M 0 0.0%

Financial report summary

?
Competition
Dusa Pharmaceuticals
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg

Proxies

No filings